| | Key Words | | Study Title
| | Status
|
| | | | | | |
| | CRT-D, Heart Failure | | The Electrophysiologic and Electrocardiographic Changes Associated with Chronic Resynchronization Therapy (CRT) | | Open to Enrollment |
| | Revascularization, Diabetes mellitus, multivessel disease, FREEDOM Trial | | Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease IDE#G040164 | | Open to Enrollment |
| | Pulmonary Arterial Pressure | | Non-Invasive Acoustic Estimation of the Pulmonary Artery Pressure | | Open to Enrollment |
| | Alloimmunity Cardiac Transplants | | Clinical Trials in Organ Transplantation (CTOT) Protocol CTOT-05. Observational Study of Alloimmunity in Cardiac Transplant Recipients | | Open to Enrollment |
| | Heart Failure | | Myocardial Hemodynamic Effects of Nesiritide | | Open to Enrollment |
| | Atrial Fibrillation | | Effect of Persistent Atrial Fibrillation on Blood Preassure | | Open to Enrollment |
| | Pre-Heart Transplant Evaluation, LVAD Evaluation | | A Comparison of Echocardiography-Derived and Invasive Hemodynamics in pre-heart transplant patients | | Open to Enrollment |
| | Atrial Fibrillation, Atrial Tachycardia, Irregular Heart Rythm | | Reducing Episodes by Septal pacing Efficacy Confirmation Trial (RESPECT) | | Open to Enrollment |
| | Heart Failure, Anemia, Hyperglocosylated Erythropoieses Stimulating Protein (Darbepoetin Alpha) | | Efficacy and Safety of Darbepoetin alfa Treatment on Mortality and Morbidity in Heart Failure Sybjects with Symptomatic Left Ventricular Systolic Dysfunction and Anemia | | Open to Enrollment |
| | Heart Failure, Idiopathic Dialated Cardiomyopathy | | Beta Blocker Effect on Remodeling and Gene Expression (BORG) | | Open to Enrollment |
| | Diastolic Dysfunction, Endothelin Receptor Type A Antagonist | | Study of Sitaxsentan Sodium to Improve Impaired Exercise Tolerance in Subjects with Diastolic Heart Failure | | Open to Enrollment |
| | Inotrope Dependent, Decompensated Heart Failure | | Trial of the Orqis Medical CRS for the Enhanced Treatment of Chronic Heart Failure Unresponsive to Medical Therapy (MOMENTUM study) | | Open to Enrollment |
| | Heart Failure NYHA Class I-III, Simvastatin, Patients without Hyperlipidemia | | The Effect of Simvastatin Therapy on the Expression of Procoagulant and Inflammatory Markers in Heart Failure | | Open to Enrollment |
| | PFO (Patent Foramen Ovale) Access Registry, IDE G060145 | | Closure of Patent Foramen Ovale with the AMPLATZER® PFO OCCLUDER in patients with at least two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale and who have failed conventional therapy. IDE# G060145 | | Open to Enrollment |
| | PFO (Patent Foramen Ovale) | | Closure of Patent Foramen Ovale with the AMPLATZER PFO OCCLUDER in patients with at least two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale and who have failed conventional therapy | | Closed to Enrollment |
| | Blood Clotting | | Utilization of D-Dimer and Prothrombin Factor 1 + 2 in Detecting Thrombosis During Diagnostic Coronary Angiogram | | Closed to Enrollment |
| | Congestive Heart Failure, Cardiac Resynchronization Therapy Defibrillator | | Decompensation Detection Study (DECODE) | | Closed to Enrollment |
| | Heart Failure | | Myocardial Hemodynamic Effects of Levosimendan | | Closed to Enrollment |
Physicians
